Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1‐receptors (Q70180035)
scientific article published on December 12, 1983
Language:
(P31) (Q13442814)
(P304) 340-344
(P407) (Q1860)
(P433) 2
(P478) 164
(P577) Thursday, December 1, 1983
Monday, December 12, 1983
(P921) (Q50429165)
(Q7141)
(Q7162)
(Q7094)
(Q908902)
(Q7100)
(P953) https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/0014-5793%2883%2980313-5
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2F0014-5793%2883%2980313-5
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2F0014-5793(83)80313-5
https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/0014-5793%2883%2980313-5
(P1433) (Q1388051)
(P1476) "Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1-receptors" (language: en)
"Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1‐receptors" (language: en)
(P2093) M. Vanderwel
D. S. Lum
R. J. Haslam
(P2860) (Q40124914)
(Q66972572)
(Q36127785)
(Q40086581)
(Q42245699)
(Q40135168)
(Q72923923)
(Q44843156)
(Q67252467)
(Q29616831)
other details
description scientific article published on December 12, 1983

External Links